Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Avimab AB
AB
Active
Org 5568384332
Tvistevägen 48 C, 907 36
Umeå
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2011 · 15 years old
0 employees
Overvåg
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Avimab AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
72
140
17
51
19
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
72
140
17
51
19
Net financials
—
—
—
—
—
Profit before tax
72
140
18
50
19
Tax
−15
−29
−4
−10
−4
Net profit
57
111
14
40
15
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
113
195
89
103
79
Equity
112
163
76
91
66
Long-term debt
0
0
0
0
0
Short-term debt
2
32
12
12
13
Total debt
2
32
12
12
13
Financial ratios
5-year trend
EBITDA-margin
1900000.0%
This company
15.8%
Market median
+12025216% vs market
2021
2025
Soliditetsgrad
83.5%
This company
38.2%
Market median
+119% vs market
2021
2025
Egenkapitalforrentning
22.7%
This company
18.4%
Market median
+23% vs market
2021
2025
Nettoresultatgrad
1500000.0%
This company
8.1%
Market median
+18518419% vs market
2021
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Gæld/egenkapital
0.20×
This company
0.62×
Market median
+68% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Avimab AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
